News and Stories About Know Your Tumor

PanCAN and partners published a study about RAF alterations in patients’ tumors.

Editor’s note: Originally published in February 2021, we’ve updated this article to include the exciting news that the first drug […]
READ MORE

Chief Science Officer Lynn Matrisian shares her priorities, proudest accomplishments.

“I’ve been an advocate for following the science throughout my journey,” survivor Jeff Eidens says. And PanCAN Patient Services has […]
READ MORE

The 2021 Gastrointestinal (GI) Cancers Symposium recently brought together oncologists, researchers, patients and patient advocates, including the Pancreatic Cancer Action […]
READ MORE

Every day in 2021, 166 Americans will learn that they have pancreatic cancer. That’s 60,430 people who are predicted to […]
READ MORE

Editor’s note: Today’s article looks back at scientific and clinical advances made in 2020 and kicks off our Year in […]
READ MORE

In its latest guidelines for the treatment of patients with metastatic pancreatic cancer, the American Society of Clinical Oncology (ASCO) […]
READ MORE

The theme for the 2020 American Society of Clinical Oncology’s (ASCO) Annual Meeting was “Unite & Conquer: Accelerating Progress Together.” […]
READ MORE

About one in four pancreatic cancer patients have changes in their tumor that suggest certain treatments may work particularly well […]
READ MORE

A recent paper published in the prestigious journal Lancet Oncology showed that the Pancreatic Cancer Action Network’s (PanCAN) Know Your […]
READ MORE

Alex Trebek shared a via video today to mark one year since he told the world he was fighting pancreatic […]
READ MORE

Pancreatic Cancer Action Network and Perthera Study in Lancet Oncology Underscores the Urgent Need for Every Pancreatic Cancer Patient to […]
READ MORE

The Pancreatic Cancer Action Network’s (PanCAN) Know Your Tumor® precision medicine service can help pancreatic cancer patients live longer. Know […]
READ MORE

“Accelerating Personalized Care” was the theme for the 2020 Gastrointestinal (GI) Cancers Symposium, which took place Jan. 23-25 in San […]
READ MORE

Editor’s note: Sadly, Gina passed away in January 2021. We are so grateful she shared her story to inspire and […]
READ MORE

For the first time ever, the five-year survival rate for pancreatic cancer has reached double digits. American Cancer Society’s Cancer […]
READ MORE

Editor’s note: This article kicks off our 2019 Year in Review series – highlighting the research advancements that you – […]
READ MORE

Editor’s note: Mary Fox passed away in January 2020. We are grateful she allowed her story to be shared. In […]
READ MORE

His father died of pancreatic cancer in 1974. For decades, Frankie Banali knew that the same disease – of which […]
READ MORE

People with pancreatic cancer and a specific type of change – or mutation – in their DNA live longer when […]
READ MORE

When the Pancreatic Cancer Action Network (PanCAN) launched its Know Your Tumor® precision medicine service, molecular profiling was offered for […]
READ MORE

Every pancreatic tumor – and every pancreatic cancer patient – is different. The Pancreatic Cancer Action Network (PanCAN) strongly recommends […]
READ MORE

This year’s American Society of Clinical Oncology (ASCO) Annual Meeting has brought 40,000 oncologists and other cancer experts from around […]
READ MORE

The morning of Feb. 5, 2016, started like many for Gail. She got up early and headed to the gym […]
READ MORE

Editor’s note: The National Comprehensive Cancer Network (NCCN), which sets guidelines for the treatment and management of pancreatic adenocarcinoma (the […]
READ MORE

The largest-ever molecular analysis of pancreatic cancer tissue samples – from more than 3,500 patients – revealed some new clues […]
READ MORE

Around Christmas 2016, Karen Kiernan was enjoying the holidays at her family home in Truckee, Calif., when she began to […]
READ MORE

A large group of Pancreatic Cancer Action Network (PanCAN) leadership and Scientific and Medical Affairs staff are attending the 2019 […]
READ MORE

Editor’s note: Welcome to the first article in our 2018 Year in Review series! Over the next couple weeks, we’ll […]
READ MORE

All cancer patients deserve the best care available, but not all can receive it. For some, the problem is financial. […]
READ MORE

The U.S. Food and Drug Administration (FDA) approved Vitrakvi® (larotrectinib) today for the treatment of any locally advanced or metastatic solid tumor, […]
READ MORE

The Atlantic’s People v. Cancer event took place Nov. 14, 2018, in New York City. The event featured a stellar […]
READ MORE

Editor’s note: Sadly, Gail Bamer died in July 2019. We are grateful to her for allowing her story to be […]
READ MORE

The Pancreatic Cancer Action Network (PanCAN) offers an Ask PanCAN Patient Services series to provide helpful tips and information about […]
READ MORE

The Pancreatic Cancer Action Network (PanCAN) has now delivered personalized molecular profiling reports to 1,000 pancreatic cancer patients through its […]
READ MORE

When doctors told David Watson of Santa Monica, Calif., that he had type 2 diabetes in November 2016, he couldn’t […]
READ MORE

A biomarker is a substance found in the body that can be measured. The amount of a biomarker may vary […]
READ MORE

Editor’s note, March 2, 2020: Results published in Lancet Oncology from the Pancreatic Cancer Action Network’s (PanCAN) Know Your Tumor® […]
READ MORE

Published today in the esteemed Clinical Cancer Research, a journal of the American Association for Cancer Research, the Pancreatic Cancer […]
READ MORE

Every pancreatic tumor is different. The Pancreatic Cancer Action Network (PanCAN) strongly recommends molecular profiling of your tumor to help […]
READ MORE

Editor’s note: Pancreatic Cancer Action Network (PanCAN) President and CEO Julie Fleshman attended the Harvard Business School (HBS) Kraft Precision […]
READ MORE

“All Cancer Patients Should Have Access To Genomic Testing” is the title of a compelling article featured in Forbes earlier […]
READ MORE

The 2018 Gastrointestinal (GI) Cancers Symposium is taking place in San Francisco, Jan. 18 to 20. The meeting brings together […]
READ MORE

Entrepreneur Skip Viragh was a collaborator. An innovator. A proactive problem-solver. A masterful leader. And he deeply valued these qualities […]
READ MORE

At the end of every year, Science magazine announces a Breakthrough of the Year – a discovery that revolutionized the […]
READ MORE

Akshay Mehta, MD, was in the middle of performing an orthopedic surgery when his first pancreatic cancer symptom arose. “I […]
READ MORE

“Let’s face it: The pancreas is a behind-the-scenes organ most of us don’t know – or think – much about. […]
READ MORE

The American Association for Cancer Research (AACR) released its annual Cancer Progress Report earlier this week. “Research continues to be […]
READ MORE

May was a busy month for pancreatic cancer precision medicine developments. Every pancreatic tumor is different. The Pancreatic Cancer Action […]
READ MORE

Editor’s note: Sadly, Josephine Scivoli passed away in November 2019. We are grateful she allowed her story to be shared. Josephine […]
READ MORE

Last week, we shared the exciting news that an immunotherapy agent, Keytruda, was the first drug approved by the FDA […]
READ MORE

For the first time, the U.S. Food and Drug Administration (FDA) has approved a cancer drug based only on molecular […]
READ MORE

The Pancreatic Cancer Action Network’s state-of-the-art Know Your Tumor® precision medicine service offers molecular profiling to eligible patients. Molecular profiling […]
READ MORE

Precision medicine is a hot topic right now, but what does the phrase even mean? In short, with precision medicine, […]
READ MORE

Pancreatic Cancer Action Network’s Know Your TumorSM Program Surpasses 1,000 Enrolled Patients MANHATTAN BEACH, Calif. – (Feb. 8, 2017) – The […]
READ MORE

Dr. Andrew E. Hendifar, the medical oncology lead for the gastrointestinal disease research group at Cedars-Sinai Medical Center, champions progress […]
READ MORE

We’ve learned a lot about pancreatic cancer in recent years, and we now know that every patient’s cancer is different […]
READ MORE